Search All News
A study of more than 500 hospitalized COVID patients found that comorbidities do not necessarily result in the worst outcomes.
Since 1955, “Merritt’s Neurology,” edited by Columbia neurologists, has been regarded as the standard reference work in the field. James Noble, MD, joins the ranks for the latest edition.
New technology will allow scientists to uncover what happens in the brain during the early stages of Parkinson's disease, which could lead to earlier diagnosis and better therapies for the disease.
- June 16, 2021
Spectacular images of a molecule that shuttles omega-3 fatty acids into the brain may open a doorway for delivering neurological therapeutics to the brain.
- May 7, 2021
Driving data captured by vehicle recording devices can help detect mild cognitive impairment and dementia in older drivers, Columbia researchers have found.
- March 30, 2021
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
- February 18, 2021
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
- February 8, 2021
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
- November 25, 2020
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
- November 12, 2020
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
- October 21, 2020
A new study of Alzheimer’s genes suggests the disease in Blacks and whites is largely the same, but genetic changes that increase the risk of developing the disease differ between the two groups.